Germanium Could Soon Diagnose COVID-19 and Other Diseases

The ability of the semiconductor metal germanium to absorb infrared radiation enables its application in medical diagnostics. Norwegian scientists are currently working on a small device that could, for example, distinguish between a common cold and COVID-19 in the future.
To achieve this, the device identifies pathogens using light. Through the use of germanium, the device can store waves in the infrared part of the light spectrum up to 100 times longer than currently available diagnostic devices. This represents a significant advancement in the development of light-based pathogen identification, although it will likely take several more years before the device reaches market maturity.
Germanium once again demonstrates its strength as a “health metal.” Furthermore, it represents an excellent investment opportunity with the potential for substantial returns, including tax-free purchase and tax-free gains after a one-year holding period.